
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SYND3/SDC3/Syndecan-3 CRISPR/Cas9 KO Plasmid (m) | sc-423236 | 20 µg | $397.00 |
Sdc3 encodes syndecan-3 (SYND3/SDC3), a transmembrane heparan sulfate proteoglycan that organizes extracellular matrix cues and growth factor gradients at the cell surface. By binding heparan sulfate–dependent ligands, SDC3 modulates receptor tyrosine kinase and chemokine signaling, influencing cytoskeletal remodeling, cell migration, neurite outgrowth, and synaptic plasticity. In mouse, Sdc3 is prominent in neuronal and metabolic tissues and contributes to pathways governing axon guidance, cell–matrix adhesion, and inflammatory signaling. Dysregulated syndecan-3 function has been associated with neurodevelopmental and neuroinflammatory processes and with altered energy balance phenotypes, supporting its use as a mechanistic node in CNS and metabolism research.
SYND3/SDC3/Syndecan-3 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Sdc3 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Sdc3 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Sdc3 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SYND3/SDC3/Syndecan-3 protein expression.
This CRISPR knockout system enables efficient generation of Sdc3-deficient cell models for investigation of SYND3/SDC3/Syndecan-3 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.